Alexander Pantelyat
Overview
Explore the profile of Alexander Pantelyat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Young C, Cholerton B, Smith A, Shahid-Besanti M, Abdelnour C, Mormino E, et al.
Neurology
. 2024 Jun;
103(2):e209609.
PMID: 38870440
Background And Objectives: Executive functioning is one of the first domains to be impaired in Parkinson disease (PD), and the majority of patients with PD eventually develop dementia. Thus, developing...
12.
Kilic-Berkmen G, Scorr L, McKay L, Thayani M, Donsante Y, Perlmutter J, et al.
Mov Disord Clin Pract
. 2024 May;
11(8):973-982.
PMID: 38778444
Background: Prior studies have indicated that female individuals outnumber male individuals for certain types of dystonia. Few studies have addressed factors impacting these sex differences or their potential biological mechanisms....
13.
Chia R, Ray A, Shah Z, Ding J, Ruffo P, Fujita M, et al.
Neuron
. 2024 May;
112(13):2142-2156.e5.
PMID: 38701790
Multiple system atrophy (MSA) is an adult-onset, sporadic synucleinopathy characterized by parkinsonism, cerebellar ataxia, and dysautonomia. The genetic architecture of MSA is poorly understood, and treatments are limited to supportive...
14.
Saloner R, Staffaroni A, Dammer E, Johnson E, Paolillo E, Wise A, et al.
Res Sq
. 2024 Apr;
PMID: 38585969
The pathophysiological mechanisms driving disease progression of frontotemporal lobar degeneration (FTLD) and corresponding biomarkers are not fully understood. We leveraged aptamer-based proteomics (> 4,000 proteins) to identify dysregulated communities of...
15.
Garcia-Cordero I, Anastassiadis C, Khoja A, Morales-Rivero A, Thapa S, Vasilevskaya A, et al.
Ann Neurol
. 2024 Apr;
96(1):99-109.
PMID: 38578117
Objectives: To evaluate the effect of Alzheimer's disease (AD) -related biomarker change on clinical features, brain atrophy and functional connectivity of patients with corticobasal syndrome (CBS) and progressive supranuclear palsy...
16.
Cheong I, Du Y, Smith G, Hua J, Li X, Pantelyat A
Neurodegener Dis
. 2024 Mar;
23(3-4):35-42.
PMID: 38527450
Introduction: Progressive supranuclear palsy (PSP) is a four-repeat tauopathy characterized by multiple clinicopathologic subtypes. Advanced neuroimaging techniques have shown an early ability to distinguish PSP subtypes noninvasively for improved diagnosis....
17.
Oertel F, Casillas D, Cobigo Y, Montes S, Heuer H, Chapman M, et al.
Acta Neuropathol
. 2024 Feb;
147(1):30.
PMID: 38308717
No abstract available.
18.
Iyer J, Gunzler D, Lang A, Golbe L, Pantelyat A, Boxer A, et al.
JAMA Neurol
. 2024 Jan;
81(3):295-297.
PMID: 38252447
No abstract available.
19.
Alshaikh J, Paul A, Moukheiber E, Scholz S, Pantelyat A
Clin Park Relat Disord
. 2023 Dec;
10:100230.
PMID: 38145206
No abstract available.
20.
Boz D, Kilic-Berkmen G, Perlmutter J, Norris S, Wright L, Klein C, et al.
Mov Disord Clin Pract
. 2023 Dec;
10(12):1777-1786.
PMID: 38094647
Background: There are several widely used clinical rating scales for documenting the severity and distribution of various types of dystonia. Objectives: The goal of this study was to evaluate the...